Cargando...

Hemophilia gene therapy comes of age

Concurrent with the development of recombinant factor replacement products, the characterization of the F9 and F8 genes over 3 decades ago allowed for the development of recombinant factor products and made the hemophilias a target disease for gene transfer. The progress of hemophilia gene therapy h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hematology Am Soc Hematol Educ Program
Autor Principal: George, Lindsey A.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142599/
https://ncbi.nlm.nih.gov/pubmed/29222308
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!